Status:
COMPLETED
A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.
Lead Sponsor:
GlaxoSmithKline
Conditions:
HIV Infection
Infection, Human Immunodeficiency Virus
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This study is a two-part study. Part one is designed to see how different formulations of GSK364735 are absorbed in the body and To see how food affects how GSK364735 is absorbed in the body. Part two...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- The subject is healthy with no clinically significant problems identified by the physician.
- Females of non-childbearing potential and males surgically sterile or agrees to birth control.
- Body mass Index (BMI) of 19-29.9 (kg/m2).
- Exclusion criteria:
- As a result of the physical examination, lab results the Investigator considers the subject unfit for the study.
- Blood pressure and electrocardiogram is not normal
- A history of alcohol or illicit drug abuse.
- Tobacco use within 3 months.
- Positive for Hepatitis B surface antigen, Hepatitis C antibody or HIV antibody.
- Current use of prescription or non-prescription drugs, including vitamins, herbal and dietary supplements.
- Has participated in a clinical trial within 30 days prior to the first dose of study medication.
- Donated a pint of blood within a 56 day period.
- History of allergy to study drug.
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00386347
Start Date
October 1 2006
Last Update
June 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Evansville, Indiana, United States, 47714